Peptide drugs to target G protein-coupled receptors

Trends in Pharmacological Sciences
Kathrin Bellmann-Sickert, Annette G Beck-Sickinger

Abstract

Major indications for use of peptide-based therapeutics include endocrine functions (especially diabetes mellitus and obesity), infectious diseases, and cancer. Whereas some peptide pharmaceuticals are drugs, acting as agonists or antagonists to directly treat cancer, others (including peptide diagnostics and tumour-targeting pharmaceuticals) use peptides to 'shuttle' a chemotherapeutic agent or a tracer to the tumour and allow sensitive imaging or targeted therapy. Significant progress has been made in the last few years to overcome disadvantages in peptide design such as short half-life, fast proteolytic cleavage, and low oral bioavailability. These advances include peptide PEGylation, lipidisation or multimerisation; the introduction of peptidomimetic elements into the sequences; and innovative uptake strategies such as liposomal, capsule or subcutaneous formulations. This review focuses on peptides targeting G protein-coupled receptors that are promising drug candidates or that have recently entered the pharmaceutical market.

Citations

Aug 25, 2012·Future Medicinal Chemistry·Verena M AhrensAnnette G Beck-Sickinger
Aug 25, 2012·Future Medicinal Chemistry·Joseph Audie, Jon Swanson
Oct 27, 2012·Advanced Drug Delivery Reviews·Kwang-Chul KwonHenry Daniell
Nov 13, 2012·Journal of Hematology & Oncology·Michael A Firer, Gary Gellerman
Feb 23, 2011·Natural Product Reports·Charles R RobertsonGrzegorz Bulaj
Jul 31, 2013·Organic & Biomolecular Chemistry·Eul-Soo ParkJong-Shik Shin
Feb 26, 2014·BMC Structural Biology·Ankur DhanikLydia E Kavraki
Feb 24, 2012·Amino Acids·Jacob Dahlqvist ClausenHenrik Franzyk
Sep 1, 2011·Expert Opinion on Medical Diagnostics·Paolo Ruzza, Andrea Calderan
Aug 14, 2012·Life Sciences·Martha G Bomar, Amit K Galande
Feb 22, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Randall J Mrsny
Jul 3, 2015·Current Opinion in Chemical Biology·Halina M Werner, W Seth Horne
Aug 20, 2011·Biomedical Chromatography : BMC·Marcello LocatelliFrancesco Epifano
Dec 21, 2012·Chemical Biology & Drug Design·David J CraikDavid Price
Jan 1, 2012·Molecular Informatics·Matteo Floris, Stefano Moro
Feb 26, 2011·Journal of Peptide Science : an Official Publication of the European Peptide Society·Cornelia WaltherAnnette G Beck-Sickinger
Feb 24, 2015·Journal of Peptide Science : an Official Publication of the European Peptide Society·David Böhme, Annette G Beck-Sickinger
Jul 30, 2014·Angewandte Chemie·Veronika MädeAnnette G Beck-Sickinger
Jul 25, 2015·Chembiochem : a European Journal of Chemical Biology·Halina M WernerW Seth Horne
Mar 17, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L MaletínskáJ Kuneš
Jul 5, 2016·Chemical Communications : Chem Comm·Allan J B Watson, James R Frost
Jul 16, 2016·The Journal of Endocrinology·Jaroslav KunešLenka Maletínská
Oct 22, 2013·Bioconjugate Chemistry·Louise AlbertsenKristian Strømgaard
May 12, 2012·Journal of Theoretical Biology·Bahram HemmateenejadMaryam Elyasi
Sep 23, 2016·Future Medicinal Chemistry·Xiayang XieYong Teng
Oct 25, 2016·Journal of Proteomics·Kristien A Van CampSteven J Husson
Oct 4, 2016·Journal of Medicinal Chemistry·Olivier Van der PoortenDirk Tourwé
Aug 8, 2018·Organic & Biomolecular Chemistry·Danil P ZarezinValentine G Nenajdenko
Feb 13, 2019·Organic & Biomolecular Chemistry·D LachmannB König
Dec 7, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yuanjun DengGang Xu
May 30, 2015·Pharmacological Reviews·Miia KovalainenKarl-Heinz Herzig
Jul 6, 2014·Beilstein Journal of Organic Chemistry·Veronika MädeAnnette G Beck-Sickinger
Dec 29, 2016·Oncotarget·Maria ManginiStefania Mariggiò

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.